Relationship between peripheral muscle force and systemic and localized muscle mass in healthy subjects, smokers and COPD patients Source: Annual Congress 2008 - Assessing profiles of rehabilitation candidates Year: 2008
Low muscle mass is a strong predictor for osteoporosis in smokers with or without COPD Source: Annual Congress 2013 –The latest insights in exercise testing and physical inactivity Year: 2013
Relationship between the tissue depletion pattern and muscle mass, muscle strength and inflammation in COPD patients Source: Annual Congress 2006 - COPD and systemic inflammation Year: 2006
Maximal exercise in obese patients with COPD. The role of the fat free mass Source: International Congress 2014 – Mechanisms of exercise limitation in health and disease Year: 2014
Influence of respiratory muscle strength and body weight on exercise metabolism in COPD patients Source: Eur Respir J 2001; 18: Suppl. 33, 490s Year: 2001
The combination of low fat-free mass and high fat mass is related to functional outcome and systemic inflammation in patients with COPD Source: International Congress 2014 – Clinical presentations Year: 2014
Effects of pulmonary rehabilitation in patients with COPD with and without fat free mass depletion Source: Annual Congress 2012 - The best posters in pulmonary rehabilitation and chronic care Year: 2012
Skeletal muscle redox status is reduced in COPD patients with low BMI Source: Eur Respir J 2003; 22: Suppl. 45, 204s Year: 2003
Altered muscle metabolism and muscle mass in patients with COPD Source: International Congress 2017 – Neuromuscular consequences of respiratory diseases Year: 2017
Comparison of functional exercise capacity, muscle strength, anaerobic power and capacity in patients with malnourished non-cystic bronchiectasis and healthy controls Source: International Congress 2015 – Physiotherapy outcomes and treatment in different patient profiles Year: 2015
Relationship between muscle mass and function and physical activity levels in patients with COPD – a longitudinal study Source: International Congress 2017 – The importance of physical activity in patients with COPD Year: 2017
Comparison of functional capacity, muscle strength, body composition in patients with cystic fibrosis, non-cystic bronchiectasis and healthy controls Source: Annual Congress 2012 - Assessment of physical activity, exercise, muscle function and clinical characteristics as outcomes in physiotherapy and rehabilitation Year: 2012
Assessment of nutrition and muscle mass loss in patients with severe COPD. Source: International Congress 2017 – Markers of COPD progression Year: 2017
Inflammatory markers in skeletal muscle of low and normal weight COPD patients Source: Annual Congress 2005 - Systemic effects of COPD Year: 2005
Association of pulmonary dysfunction with physical inactivity and loss of muscle mass in elderly COPD patients Source: Annual Congress 2013 –Respiratory and cardiovascular abnormalities in COPD: the role of exercise, nutritional status and inflammation Year: 2013
Reliability of using magnetic stimulation to evaluate muscle function in patients with severe to very severe COPD and healthy subjects Source: International Congress 2016 – Effects of exercise training interventions in chronic respiratory disease Year: 2016
A comparison of lung function, respiratory and peripheral muscle strength, and functional capacity in low and high-fatigue patients with COPD Source: Annual Congress 2010 - Respiratory muscle function and training in acute and chronic respiratory disease Year: 2010
Whole-body resting and exercise-induced lipolysis in sarcopaenic patients with COPD Source: Eur Respir J 2008; 32: 1466-1471 Year: 2008
Lung function, respiratory muscle strength, functional capacity, and peripheral muscle endurance between patients with suppurative lung disease and healthy subjects Source: Annual Congress 2008 - Pulmonary rehabilitation for non-COPD and severe COPD; field exercise testing Year: 2008
Impaired coordination of skeletal muscle protein turnover signalling in sarcopenic COPD patients Source: International Congress 2016 – How the understanding og molecular and genomic crosstalk is helping to diagnose lung disease Year: 2016